Skip to main content

Anti-ulcer therapy

Past to present

Digestive Diseases and Sciences volume 30, pages 36S–42S (1985)Cite this article

Abstract

Until 1950 the clinical treatment of peptic ulcer disease relied on dieting and antacids. However, recent controlled studies suggest that the natural course of peptic ulcer disease is not affected by diet. Antacids are primarily used to relieve distress, although high-and low-dose antacid regimens have been reported to promote duodenal ulcer healing. Initial favorable reports following the introduction of synthetic anticholinergic drugs have not been confirmed. Pirenzepine is an anticholinergic compound with a specific action on the muscarinic receptors of the parietal cells. Although pirenzepine appears effective in peptic ulcer, the results obtained in different centers have not been uniform. Sucralfate and tripotassium dicitrato bismuthate both act locally by coating the ulcer crater, the latter agent also liberating prostaglandins. Most prospective studies suggest that both drugs are effective when compared with placebo. Carbenoxolone heals 70% of gastric ulcers but is less effective against duodenal ulcers, and has a high incidence of side-effects. Treatment of peptic ulcer in the 1980s has been dominated by the advent of the H2-blockers, cimetidine and ranitidine. Peptic ulcer healing rates are similar with both drugs, and the main problem is how often and how much should be given in order to provide acceptable healing and to prevent ulcer recurrence. Other H2-blockers are being tested and they may be more effective either by healing more ulcers or healing them earlier. The clinical treatment of peptic ulcers will in future be advanced by the addition of two new classes of drugs, the prostaglandins and the benzimidazole derivatives, which are currently being investigated and appear extremely promising.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Bicalho SA: O efeito de três esquemas terapêuticos sobre o pH do conteúdo gástrico em pacientes com úlcera duodenal. Tese de Livre-Docência. Fac Med Univ Minas Gerais. Belo Horizonte, 1976

  2. Sippy BW: Gastric and duodenal medical cure by an efficient removal of gastric acid secretion. JAMA 64:1625–1630, 1915

    Google Scholar 

  3. Sturdevant RAL, Isenberg JI, Scarist D, Ansfield J: Antacids and placebo produced similar pain relief in duodenal ulcer patients. Gastroenterology, 72:1–5, 1977

    Google Scholar 

  4. Baume PE, Hunt JH: Failure of potent antacid therapy to hasten healing in chronic gastric ulcers. Aust Ann Med 18:113–116, 1969

    Google Scholar 

  5. Hollander D, Harlan J: Antacids vs. placebo in peptic ulcer therapy: a controlled double-blind investigation. JAMA 226:1181–1185, 1973

    Google Scholar 

  6. Peterson WL, Sturdevant RAL, Frankl HD: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341–345, 1977

    Google Scholar 

  7. Walan A: Anticholinergic in the treatment of ulcer disease.In Peptic Ulcer Disease. Advances in Pathogenesis and Treatment, G Bianchi Porro KD Bardhan (eds). Verona, Cortina International, 1982, C. 10

    Google Scholar 

  8. Bieberdorf FA, Walsh JH, Fordtran JS: Effect of optimum therapeutic dose of poldine on acid secretion, gastric acidity, gastric emptying and serum gastrin concentration after a protein meal. Gastroenterology 68:50–57 1975

    Google Scholar 

  9. Adami HO, Bjöklung O, Enander LK, Gustavsson S, Loof L, Nordhal A, Rosen A: Cimetidine or propantheline combined with antacid therapy for short-term treatment of duodenal ulcer. Dig Dis Sci 27:388–393, 1982

    Google Scholar 

  10. Feldman M, Richardson CT, Peterson WL, Walsh JH, Fordtran JS: Effect of low-dose propantheline of foodstimulated gastric acid secretion. N Engl J Med 26:1427–1430, 1977

    Google Scholar 

  11. Grimson KS: A clinical trial of banthine in cases of peptic ulcer. Gastroenterology 14:583–586, 1950

    Google Scholar 

  12. Cheli R, Ciancamerla G, Giacosa A, Mohinari R, Turello U: Short-term cimetidine treatment of duodenal ulcer. Comparison with placebo and an anticholinergic drug. Ital J Gastroenterol 10:18–20, 1978

    Google Scholar 

  13. Ström M, Gotthard R, Bodemar G, Walan A: Anticholinergics in the treatment of ulcer diseases.In Advances in Ulcer Diseases, KH Holtermüller, JR Malagelada (eds). Amsterdam Excerpta Médica, 1980 pp 395–405 (International Congress Series, 537)

    Google Scholar 

  14. Ivey KJ: Anticholinergics: do they work in peptic ulcer. Gastroenterology 68:154–166, 1975

    Google Scholar 

  15. Ruffin JM, Cayer D: The role of anticholinergic drugs in treatment of peptic ulcer disease. Ann NY Acad Sci 99:179–201, 1962

    Google Scholar 

  16. Lennard-Jones JE: Medical management of peptic ulcer.In Topics in Gastroenterology, SC Truelove, DP Jewele (eds). Oxford, Blackwell, 1973, pp 76–96 C.7

    Google Scholar 

  17. Gutman RA: Le Diagnostic du Cancer d'Estomach a la Periode Utile. Doin, Paris, 1946

    Google Scholar 

  18. Pounder RE, Williams JG, Russell RCG, Milton-Thompson GJ, Misiewicz JJ: Inhibition of food-stimulated gastric acid secretion by cimetidine. Gut 18:161–164, 1976

    Google Scholar 

  19. Longstreth GF, Vlw GO, Malagelada JR: Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer. N Engl J Med 294:801–804, 1976

    Google Scholar 

  20. Ippoliti A, Elashoff J, Valenzuela J, Cano R, Frankl H, Samloff M, Koretz R: Recurrent ulcer after successful treatment with cimetidine and antacid. Gastroenterology 85:875–880, 1983

    Google Scholar 

  21. Zaterka S, Ferreira JCR, Neves DP: Cimetidine no tratamento da úlcera duodenal—estudo duplamente cego. Rev Hosp Clín Fac Med Sao Paulo 33:5–11, 1978

    Google Scholar 

  22. Zaterka S, Neves DP, Silva JJ, Bettarello A: Tratamento da úlcera duodenal com cimetidine a longo prazo: estudo em aberto. Rev Hosp Clín Fac Med Sao Paulo 34:227–231, 1979

    Google Scholar 

  23. Salgado JA, Oliveira CA, Lima JGF, Paula Castro L: Endoscopic findings after antacid, cimetidine and placebo for peptic ulcer. Importance of staging the lesions. Arq Gastroenterol 18:51–53, 1981

    Google Scholar 

  24. Ippoliti AF, Sturdevant RAL, Isenberg JI, Bonder M, Camacho R, Cano C, Cooney MM, Klim MM, Koretz RL, Meyer JH, Samloff IM, Schwabe EA, Strön JE, Valenzuela JE, Wintroub RH: Cimetidine versus intensive antacids therapy for duodenal ulcer. Multicentric trial. Gastroenterology 74:393–395, 1978

    Google Scholar 

  25. Villalobos JJ, Elizondo J, Guevara L, Centeno F: Cimetidine in the treatment of duodenal ulcer: double-blind study. J Int Med Res 6:351–354, 1978

    Google Scholar 

  26. Bardhan KD: The short and medium-term treatment of duodenal ulcer with cimetidine.In Peptic Ulcer Diseases. Advances in Pathogenesis and Treatment, G Bianchi Porro, KD Bardhan (eds). Verona, Cortina International 1981, pp 85–106

    Google Scholar 

  27. Ciclitira PJ, Machell RJ, Farthing MJ, Dick AP, Hunter J: A controlled trial of cimetidine in the treatment of gastric ulcer.In Cimetidine, WL Burland, MA Simkins (eds). Amsterdam, Excerpta Medica, 1977, 283 pp

    Google Scholar 

  28. Silva EP, Zaterka S: Long-term treatment of gastric ulcer with cimetidine. Clin Ther 4:24–31, 1981

    Google Scholar 

  29. Lorber SH: U.S. trial of carbenoxolone (Biogastrone in gastric ulcer).In North American Symposium on Carbenoxolone, IT Beck (ed). Amsterdam, Excerpta Medica, 1976, pp 93–97

    Google Scholar 

  30. Hunt RH, Vincent SH, Milton-Thompson GJ, Pounder RE, Taylor ER, Misiewicz JJ, Golding PL, Colin-Jones DG: Short communication: cimetidine in the treatment of gastric ulcer.In Cimetidine, ML Burland, MA Simkins (eds). Amsterdam, Excerpta Medica, 1977, 293 pp

    Google Scholar 

  31. Goebel H, Hotz J: Side effects on the histamine H2 receptor antagonists and their implication for ulcer therapy.In Advances in Ulcer Diseases, KH Holtermüller, JR Malagelada (eds). Amsterdam, Excerpta Medica, 1980, pp 366–375

    Google Scholar 

  32. Holtermüller KH, Weis H, Herzog P, Rothmund M, Gröninger J: Medical therapy of ulcer disease after gastric resection.In Advances in Ulcer Disease, KH Holtermüller, JR Malagelada (eds). Amsterdam, Excerpta Medica, 1980, pp 347–356

    Google Scholar 

  33. Zaterka S, Silva JJ, Bettarello A: Cimetidine no tratamento du úlcera recidivante após gastrectomia parcial. Rev Hosp Clín Fac Med Sao Paulo 27:25–29, 1982

    Google Scholar 

  34. Festen HPM, Larners CBH, Driessen WMM, Van Tongeren JHM: Cimetidine in anastomotic ulceration after partial gastrectomy. Gastroenterology 86:83–87, 1979

    Google Scholar 

  35. Walt RP, Male RJ, Rowlings J, Torrie P, Hunt RH, Misiewicz JJ, Milton-Thompson GP: 24-hours intra-gastric acidity in duodenal ulcer patients on a new twice-daily H2 receptor antagonist. Gut 20:904A, 1979

    Google Scholar 

  36. Dobrilla G, De Pretis G, Felder M, Chivoli F: Endoscopic double-blind controlled trial of ranitidine vs. placebo in short-term treatment of duodenal ulcer. Hepatogastroenterology 28:49–52, 1981

    Google Scholar 

  37. Costa ACT, Zeitune JMR, Bettarello A: Estudo duplo cego com a ranitidine no tratamento da úlcera péptica duodenal. Rev Bras Med 39:461–465, 1982

    Google Scholar 

  38. Ashton MG, Holdsworth CD, Ryan FP, Moore M: Healing of gastric ulcers after one, two and three months of ranitidine. Br Med J 284:467–468, 1982

    Google Scholar 

  39. Bonfils S, Mignon M: Management of Zollinger-Ellison syndrome.In Advances in ulcer disease, KH Holtermüller, JR Malagelada (eds). Amsterdam, Excerpta Medica, 1980, pp 357–365

    Google Scholar 

  40. Mazzaca G, Sabbatini, F, Barbara L, Mighioli M, Bianchi Porro G, Lazzaroni M, Dobrilla G, Chivoli F, Verne G, Pera A: Tratamento dell'ulcera duodenale con ranitidina: studio a longo termine.In Terapia Médica Farmacológica dell'ulcera duodenale, G Bianchi Porro (ed). Medicina Rev EMI 2:121–148, 1982

  41. Silva JJ, Carneiro-Leão G, Zaterka S, Bettarello A: Avaliacão clínica, endoscópica e histológica no tratamento da úlcera duodenal: efeito da droga alcalina, anti-péptica e de placebo. Rev Hosp Clin Fac Med Sao Paulo 33:158–162, 1978

    Google Scholar 

  42. Marks IN, Lucky H, Wright GP: Comparison of sucralfate with cimetidine in short-term treatment of chronic peptic ulcers.In International Congress of Gastroenterology. 11°, Hamburg, June 8–13, 1980. Abstracts. Stuttgart, Thieme, 1980. Hepato-gastroenterology 1980, pp 383

    Google Scholar 

  43. Hollander D: Sucralfate: new agent for treatment of duodenal ulcer.In International Congress of Gastroenterology. 11° Hamburg, June 8–13 1980. Abstract., Stuttgart, Thieme, 1980. Hepato-gastroenterology 1980, 382 pp

    Google Scholar 

  44. Bianchi Porro G, Petrillo M: Pirenzepine in the treatment of peptic ulcer disease. Review and commentary. Scand J Gastroenterol 17(Suppl 72):229–236, 1982

    Google Scholar 

  45. Silva JJ, Zaterka S, Bettarello A Pirenzepina no tratamento da úlcera duodenal. Estudo duplamente cego. Gastroenterol Endosc Dig 3(2): 1984 (in press)

  46. Burnner H, Dittich H, Kratochvil P, Brandstätter G, Hentschel E, Schütze K, Tragl KH, Kern H, Löffelman K, Zeiler H, Czitober H, Publig W, Zandl C, Weiss W, Rüdiger E, Pötzi R, Lochs H, Polterauer P, Reichel W, Kerstan E, Bauer P: Treatment of duodenal ulcer with pirenzepine and cimetidine. Gut 25:206–210, 1984

    Google Scholar 

  47. Zaterka S, Ferreira JCR, Vieira LG: Tratamento da ulcera duodenal com LS-519 (pirenzepina). Comparação entre dois esquemas posológicos. Gastroenterologia Endoscopia Digestiva 1:62–67, 1982

    Google Scholar 

  48. Osseladore D, Chierichetti SM, Norberto L, Vibelli C: Pirenzepine (LS-519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial. Scand J Gastroenterol 14(Suppl 57):33–40, 1979

    Google Scholar 

  49. Morelli A, Narducci F, Pelli MA, Spadacini A: A doubleblind short-term clinical trial of pirenzepine in duodenal ulcer. Scand J Gastroenterol 14 (Suppl 57):45–50, 1979

    Google Scholar 

  50. Vantrappen G, Rutgeerts P, Broekaert L, Janssens J: Randomized open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Gut 21:329–333, 1980

    Google Scholar 

  51. Salmon PR, Brown P, Williams R, Read AE: Evaluation of colloidal bismuth (De Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up. Gut 15:189–193, 1974

    Google Scholar 

  52. Boyes BE, Woolf IL, Wilson RY, Cowley DJ, Dymock IW: Effective treatment of gastric ulceration with a Bismuth preparation. Gut 15:833, 1974

    Google Scholar 

  53. Doll R, Hill ID, Hutton CF, Underwood DJ: Clinical trial of triterpenoid liquorice compound in gastric and duodenal ulcer. Lancet 1:793–796, 1962

    Google Scholar 

  54. Hadzic N, Vrhovac B, Kallai L: Controlled double-blind trial of carbenoxolone in gastric and duodenal ulcer. Int J Clin Pharmacol 10:309–318, 1974

    Google Scholar 

  55. Taylor RH, Laidlow JM, Chapman RG, Colin-Jones DG, Golding PL, Hunt RH, Vincent H, Milton-Thompson GJ, Misiewicz JJ: Double-blind trial comparing cimetidine with carbenoxolone in the treatment of benign gastric ulcer. Gut 18:A420, 1977

    Google Scholar 

  56. Christensen E, Juhl E, Tygetrup N: Treatment of duodenal ulcer: randomized clinical trial of a decade (1964–1974). Gastroenterology 73:1170–1178, 1974

    Google Scholar 

  57. Korman MG, Hansky J, Eaves RE, Schmidt GT: Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology 85:871–874, 1983

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Internal Medicine, Medical School of Sao Paulo, Sao Paulo, Brazil

    A. Bettarello MD

Authors
  1. A. Bettarello MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bettarello, A. Anti-ulcer therapy. Digest Dis Sci 30, 36S–42S (1985). https://doi.org/10.1007/BF01309383

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01309383

Keywords

  • Peptic Ulcer
  • Duodenal Ulcer
  • Ranitidine
  • Peptic Ulcer Disease
  • Ulcer Healing